Catch Octave on NYSE FloorTalk: See How We’re Advancing Precision Medicine in MS Watch
Catch Octave on NYSE FloorTalk: See How We’re Advancing Precision Medicine in MS Watch
“Without Octave, it’s like my medical team is in the dark, but this technology’s data is like turning on a light or removing blinders.”
– Brittany, an Octave Patient
For people diagnosed and living with multiple sclerosis. Octave provides a new way for managing your MS with its precision care solution.
Every person living with multiple sclerosis (MS) is unique and there are limited tools available which measure disease activity over time. MS disease activity results from inflammation occurring in your brain or spinal cord. Evidence of MS disease activity may be observed by the presence of active lesions on your MRI. Octave’s Multiple Sclerosis Disease Activity (MSDA) Test enables you to measure this activity through a simple blood test based on the levels of 18 proteins in the blood that gives you a numeric score to measure and track your disease activity over time.
test
“An MS diagnosis comes with a hundred question marks, and it’s tough because you’re battling something you can’t even see. Octave can be life-changing for all of us dealing with this disease. It helps me understand my progress better and spot problem areas that even MRI scans might miss.
With Octave, I feel like I have more control over a disease that is notoriously difficult to manage. And it gives my medical team an edge; they can treat me more effectively when they can see what’s going on inside. Without Octave, it’s like they’re in the dark, but this technology’s data is like turning on a light or removing blinders.
Knowing how my disease is responding to my treatment has given me so much more confidence than just hoping that it’s working.”
– Brittany
First, your provider orders your MSDA test, and your labs are drawn.
Then, your samples are received by Octave for test processing.
Finally, the MSDA Test results are delivered to your ordering provider, and a claim is submitted to the insurance, or processed as Cash Pay.
The Octave MSDA Test measures the levels of 18 proteins in your blood. The results are presented in a report shared with your doctor, which contains an overall disease activity score and four biological pathway scores reported as Low (1.0-4.0), Moderate (4.5-7.0) and High (7.5-10.0). Included in the report are also the individual 18 protein measurements with their respective scores.
The Octave MSDA Test is designed to measure the likelihood of new MS lesions seen on MRI scans. If you have a disease activity score that is High, you are more likely to have new MRI lesions than if you have a Low or Moderate score.1 These scores often change over time, so it’s important to repeat testing on an ongoing basis. Moreover, the pathway scores can provide you and your provider more insight about your disease activity.
The Octave MSDA Test must be ordered by a prescribing healthcare provider. Talk to your doctor to learn more about how they can order the test for you. Click here for an example to help guide your discussions.
Each clinic has their own protocol for where patients can get their blood drawn. The test is intended to monitor your disease over time, so your doctor may set a schedule for how often you will receive the test in a year.
Your doctor will receive your report with the results approximately 7 days after Octave receives your sample. Your doctor may share the results with you and mutually decide on the best actions.
Octave is actively working to have all health plans to cover this test. Octave offers support to patients in understanding and managing the insurance and billing aspects related to the Octave MSDA Test. Click here to learn more.
